Related Experiment Videos
Malignant hypercalcemia in vulvar cancer.
R Bilenchi1, S Poggiali, C Pisani
1Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy. bilenchi@unisi.it
Minerva Ginecologica
|October 6, 2005
Summary
Humoral hypercalcemia of malignancy (HHM), a paraneoplastic syndrome, is rarely linked to vulval cancer. This report details the first documented case of HHM in vulval cancer with high parathyroid hormone-related protein (PTHrP) levels.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Humoral hypercalcemia of malignancy (HHM) is a frequent paraneoplastic syndrome.
- It is commonly associated with lung, kidney, and breast cancers, but rarely with vulval cancer.
- HHM is typically caused by elevated parathyroid hormone-related protein (PTHrP) levels.
Observation:
- A case report of a 70-year-old female patient with extensive squamous cell epithelioma of the vulva is presented.
- The patient presented with symptoms consistent with HHM.
- This presentation is unusual given the rarity of HHM in vulval malignancies.
Findings:
- The patient exhibited high serum concentrations of parathyroid hormone-related protein (PTHrP).
- Immunohistochemical analysis confirmed PTHrP production by the neoplastic vulval cells.
- This provides direct evidence linking vulval squamous cell carcinoma to PTHrP overproduction.
Implications:
- This case expands the known spectrum of cancers associated with HHM.
- It highlights the importance of considering HHM in patients with vulval cancer presenting with hypercalcemia.
- The findings underscore the role of PTHrP as a key mediator in HHM, even in rare cancer types.